MedPath

Urological Deterioration in Secondary Tethered Cord Syndrome and Clue to Detect It

Completed
Conditions
Neurogenic Bladder
Tethered Spinal Cord Syndrome
Interventions
Procedure: Redo-tethering operation
Registration Number
NCT04483570
Lead Sponsor
Seoul National University Hospital
Brief Summary

Secondary tethered cord syndrome (STCS) has been diagnosed with signs of progressive deterioration in urological or neuroorthopedic systems following primary tethering surgery. However, there is no convincing urological diagnostic clue for STCS.

Detailed Description

Tethered cord syndrome (TCS) refers to various problems involving neurologic, orthopedic, and urologic systems, seen as a result of chronic traction of the spinal cord in patients with spinal dysraphism. Evidence for neural injury is often assumed irreversible, so untethering is justified to maintain neural function and prevent further neural damage. Unfortunately, some patients experienced an aggravation of symptoms following untethering. The probable causes are assumed to be the neural injury before or during operation, which was revealed along with dysplastic neural function, neural compression by increasing syrinx and secondary tethered cord syndrome (STCS) in which postoperative neural adhesion or syrinx limit motion of spinal and elicit ischemic changes as the spine grows during puberty. The Secondary Tethered Cord Syndrome is reported as 19% of cases and causes significant progressive morbidities in those who affected.

Unfortunately, the detection of STCS is not as simple as it thought. Although magnetic resonance imaging (MRI) often reveals that the cord seems to get straightened, this does not necessarily mean that is a significant tethering or cord associated with progressive nerve damage. The variable course of progression and involvement of multiple systems such as lower extremity, bladder, bowel, and back would not allow a single specialist to draw conclusions about the presence of secondary tethered cord syndrome. Moreover, the untethering procedure of STCS may not always be safe and effective. Given the fact that a significant number of 'no improvement' or new onset complications following redo-untethering, the surgery could not be attempted without clear evidence. This explains the reason there is only a limited number of relevant studies so far.

In this study, it aims to delinate the genuine features of secondary tethered cord syndrome by selecting and analyzing only cases with symptom improvements. Furthermore, it described their natural history and time course of urological deterioration and characterized by the urodynamic changes before and after the redo-untethering.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Children with signs of progressive deterioration in urological or neuroorthopedic system following primary untethering surgery.
Exclusion Criteria
  • Children without signs of progressive in urological or neuroorthopedic system following primary untethering surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Secondary Tethered Cord SyndromeRedo-tethering operationChildren with signs of progressive deterioration in urological or neuroorthopedic system, and suspected Secondary Tethered Cord Syndrome (STCS) following primary untethering surgery.
Primary Outcome Measures
NameTimeMethod
Pre-operative evaluation: Dysfunctional voidingBaseline

Evaluating any presence of urinary and fecal incontinence before the secondary tethered cord syndrome operation.

Pre-operative evaluation: Presence of Urinary Tract Infection (UTI)Baseline

Evaluating any presence of urinary and fecal incontinence before the secondary tethered cord syndrome operation

VUD (Video Urodynamic Studies)2 years after the operation

Measuring changes in maximal cystometric capacity, compliance, estimated bladder after the operation of the secondary tethered cord syndrome

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath